Skeletal muscle oxidative metabolism in an animal model of pulmonary emphysema: Formoterol and skeletal muscle dysfunction

American Journal of Respiratory Cell and Molecular Biology

Volumn 48, Issue 2, 2013, Pages 198-203

  Sullo, Nikol ^a   Roviezzo, Fiorentina ^b   Matteis, Maria ^a   Spaziano, Giuseppe ^a   Del Gaudio, Stefania ^a   Lombardi, Assunta ^b   Lucattelli, Monica ^c   Polverino, Francesca ^d   Lungarella, Giuseppe ^c   Cirino, Giuseppe ^b   Rossi, Francesco ^a   D'Agostino, Bruno ^a  

^a Department of Experimental Medicine   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d Cava de' Tirreni Hospital   (Italy)

Author keywords

COX activity; Long acting agonists; Mitochondrial adenosine diphosphate stimulated respiration; Pulmonary emphysema; Skeletal muscle dysfunction

Indexed keywords

ADENOSINE DIPHOSPHATE; CYTOCHROME C OXIDASE; FORMOTEROL; MITOCHONDRIAL DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TUMOR NECROSIS FACTOR ALPHA;

AEROBIC METABOLISM; AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOGENESIS; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOLOGY; LUNG EMPHYSEMA; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOUSE; MYOPATHY; NONHUMAN; OXYGEN CONSUMPTION; SKELETAL MUSCLE;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; ANIMALS; BRONCHODILATOR AGENTS; DISEASE MODELS, ANIMAL; DNA, MITOCHONDRIAL; EMPHYSEMA; ETHANOLAMINES; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; OXIDATION-REDUCTION; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873346071     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2012-0167OC     Document Type: Article

References (44)

1. Mostert R, Goris A, Weling-Scheepers C, Wouters EFM, Schols AM. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 2000;94:859-867.
2. American Thoracic Society/European Respiratory Society. Skeletal muscle dysfunction in chronic obstructive pulmonary disease: a statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999;159:S1-S40.
3. Agustí AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003;21:347-360.
4. Wouters EF, Creutzberg EC, Schols AM. Systemic effects in COPD. Chest 2002;121:127S-130S.
5. Agustì AG, Sauleda J, Miralles C, Gomez C, Togores B, Sala E, Batle S, Busquets X. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166: 485-489.
6. Degens H, Swisher AK, Heijdra YF, Siu PM, Dekhuijzen PNR, Alway SE. Apoptosis and ID2 expression in diaphragm and soleus muscle from the emphysematous hamster. Am J Physiol Regul Integr Comp Physiol 2007;293:R135-R144.
7. Orozco-Levi M, Lloreta J, Minguella J, Serrano S, Broquetas JM, Gea J. Injury of the human diaphragm associated with exertion and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1734-1739.
8. Grassino A, Hayot M, Czaika G. Biology of muscle injury and repair. Arch Bronconeumol 2000;36:344-350.
9. Rabinovich RA, Bastos R, Ardite E, Llinàs L, Orozco-Levi M, Gea J, Vilaró J, Barberà JA, Rodríguez-Roisin R, Fernández-Checa JC, et al. Mitochondrial dysfunction in COPD patients with low body mass index. Eur Respir J 2007;29:643-650.
10. Maltais F, LeBlanc P, Whittom F, Simard C, Marquis K, Bélanger M, Breton MJ, Jobin J. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax 2000; 55:848-853.
11. Ribera F, N'Guessan B, Zoll J, Fortin D, Serrurier B, Mettauer B, Bigard X, Ventura-Clapier R, Lampert E. Mitochondrial electron transport chain function is enhanced in inspiratory muscles of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:873-879.
12. Miura S, Kawanaka K, Kai Y, Tamura M, Goto M, Shiuchi T, Minokoshi Y, Ezaki O. An increase in murine skeletal muscle peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) mRNA in response to exercise is mediated by β-adrenergic receptor activation. Endocrinology 2007;148:3441-3448.
13. Sauleda J, Garcia-Palmer F, Wiesner RJ, Tarraga S, Harting I, Tomás P, Gómez C, Saus C, Palou A, Agustí AG. Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1413-1417.
14. Mottillo EP, Shen XJ, Granneman JG. Role of hormonesensitive lipase in beta-adrenergic remodelling of white adipose tissue. Am J Physiol Endocrinol Metab 2007;293:E1188-E1197.
15. Nisoli E, Regianini L, Briscini L, Bulbarelli A, Busetto L, Coin A, Enzi G, Carruba MO. Multiple symmetric lipomatosis may be the consequence of defective noradrenergic modulation of proliferation and differentiation of brown fat cells. J Pathol 2002;198:378-387.
16. Wills LP, Trager RE, Beeson GC, Lindsey CC, Peterson YK, Beeson CC, Schnellmann RG. The β2-adrenoceptor agonist formoterol stimulates mitochondrial biogenesis. J Pharmacol Exp Ther 2012;42:106-118.
17. Gardi C, Cavarra E, Calzoni P, Marcolongo P, de Santi M, Martorana PA, Lungarella G. Neutrophil lysosomal dysfunctions in mutant C57Bl/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors. Biochem J 1994;299:237-245.
18. Martorana PA, Brand T, Gardi C, van Even P, de Santi MM, Calzoni P, Marcolongo P, Lungarella G. The pallid mouse: a model of genetic alpha 1-antitrypsin deficiency. Lab Invest 1993;68:233-241.
19. De Santi MM, Martorana PA, Cavarra E, Lungarella G. Pallid mice with genetic emphysema: neutrophil elastase burden and elastin loss occur without alteration in the bronchoalveolar lavage cell population. Lab Invest 1995;73:1-8.
20. Thurlbeck WM. Measurement of pulmonary emphysema. Am Rev Respir Dis 1967;95:752-764.
21. Thurlbeck WM. Internal surface area of nonemphysematous lung. Am Rev Respir Dis 1967;95:765-773.
22. Barre H, Bailly L, Rouanet JL. Increased oxidative capacity in skeletal muscle from cold-acclimated ducklings: a comparison with rats. Comp Biochem Physiol B 1987;88:519-522.
23. Parfait B, Rustin P, Munnich A, Rötig A. Co-amplification of nuclear pseudogenes and assessment of heteroplasmy of mitochondrial DNA mutations. Biochem Biophys Res Commun 1998;247:57-59.
24. Adhihetty PJ, Irrcher I, Joseph AM, Ljubicic V, Hood DA. Plasticity of skeletal muscle mitochondria in response to contractile activity [review]. Exp Physiol 2003;88:99-107.
25. Hafner RP, Brown GC, Brand MD. Analysis of the control of respiration rate, phosphorylation rate, proton leak rate and proton motive force in isolated mitochondria using the "top-down" approach of metabolic control theory. Eur J Biochem 1990;188:313-319.
26. Radom-Aizik S, Kaminski N, Hayek S, Halkin H, Cooper DM, Ben-Dov I. Effects of exercise training on quadriceps muscle gene expression in chronic obstructive pulmonary disease. J Appl Physiol 2007;102:1976-1984.
27. D'Agostino B, Polverino M, Cirino G, Lombardi A, Grassi B, Sullo N, Santoriello C, Polverino F, Orlotti D, Matteis M, et al. Exercise capacity and cytochrome oxidase activity in muscle mitochondria of COPD patients. Respir Med 2010;104:83-90.
28. Samavati L, Lee I, Mathes I, Lottspeich F, Hüttemann M. Tumor necrosis factor alpha inhibits oxidative phosphorylation through tyrosine phosphorylation at subunit I of cytochrome c oxidase. J Biol Chem 2008;283:21134-21144.
29. Feder LS, Stelts D, Chapman RW, Manfra D, Crawley Y, Jones H, Minnicozzi M, Fernandez X, Paster T, Egan RW, et al. Role of nitric oxide on eosinophilic lung inflammation in allergic mice. Am J Respir Cell Mol Biol 1997;17:436-442.
30. Yoshida M, Sakiyama S, Kenzaki K, Toba H, Uyama K, Takehisa M, Kondo K, Tangoku A. Functional evaluation of pallid mice with genetic emphysema. Lab Invest 2009;89:760-768.
31. Keil M, Lungarella G, Cavarra E, van Even P, Martorana PA. A scanning electron microscopic investigation of genetic emphysema in tight-skin, pallid, and beige mice, three different C57Bl/6J mutants. Lab Invest 1996;74:353-362.
32. Barrientos A, Casademont J, Cardellach F, Ardite E, Estivill X, Urbano-Márquez A, Fernández-Checa JC, Nunes V. Qualitative and quantitative changes in skeletal muscle mtDNA and expression of mitochondrial-encoded genes in the human aging process. Biochem Mol Med 1997;62:165-171.
33. Gadaleta MN, Rainaldi G, Lezza AMS, Milella F, Fracasso F, Polosa P, Cantatore P. Mitochondrial DNA copy number and mitochondrial DNA deletion in adult and senescent rats. Mutat Res 1992;275:181-193.
34. Pikò L. Accumulation of mtDNA defects and changes in mtDNA content in mouse and rat tissues with aging. Ann N Y Acad Sci 1992;21:450-452.
35. Djouadi F, Bastin J, Gilbert T, Rötig A, Rustin P, Merlet-Benichou C. Mitochondrial biogenesis and development of respiratory chain enzymes in kidney cells: role of glucocorticoids. Am J Physiol 1994;267:C245-C254.
36. Koekemoer TC, Oelofsen W. Properties of porcine white adipose tissue and liver mitochondrial subpopulations. Int J Biochem Cell Biol 2001; 33:889-901.
37. Masuyama M, Iida R, Takastsuka H, Yasuda T, Matsuki T. Quantitative change in mitochondrial content in various mouse tissues during aging. Biochim Biophys Acta 2005;1723:302-308.
38. Valerio A, Cardile A, Cozzi V, Bracale R, Tedesco L, Pisconti A, Palomba L, Cantoni O, Clementi E, Moncada S, Carruba MO, Nisoli E. TNF-α downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J Clin Invest 2006;116:2791-2798.
39. Hood DA. Invited review: contractile activity-induced mitochondrial biogenesis in skeletal muscle. J Appl Physiol 2001;90:1137-1157.
40. Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 2005;1:361-370.
41. Scarpulla RC. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 2008;88:611-638.
42. Adhihetty PJ, Uguccioni G, Leick L, Hidalgo J, Pilegaard H, Hood DA. The role of PGC-1alpha on mitochondrial function and apoptotic susceptibility in muscle. Am J Physiol Cell Physiol 2009;297:C217-C225.
43. Lecaillon JB, Kaiser G, Palmisano M, Morgan J, Della Cioppa G. Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via aerolizer. Eur J Clin 1999;55:131-138.
44. Derks MG, van den Berg BT, van der Zee JS, Braat MC, van Boxtel CJ. Biphasic effect-time courses in man after formoterol inhalation: eosinopenic and hypokalemic effects and inhibition of allergic skin reactions. J Pharmacol Exp Ther 1997;283:824-832.